| Registry | NCT07088900 |
|---|---|
| Status | Recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: double, prevention |
| Enrollment | 60 (Estimated) |
| Sponsor | Ain Shams University (Other) |
| Conditions | Appendectomy, Pediatric |
| Interventions | caudal block using dexmedetomidine with bupivacaine, caudal block with bupivacaine (Procedure) |
| Dates | start 2025-08-01, primary completion 2026-06-30 (estimated), completion 2026-07-30 (estimated), first posted 2025-07-28, last updated 2026-05-06 |
| Locations | 1 site in Egypt |
Related Papers Related Patents Related Grants Related Experts
All trials for Appendectomy All trials for Pediatric All trials of caudal block using dexmedetomidine with bupivacaine All trials of caudal block with bupivacaine
This study aims to evaluate if adding dexmedetomidine to bupivacaine in a caudal block can provide longer and better quality pain relief for children after open appendectomy surgery. The study will also assess the effect of this combination on the quality of recovery, including the incidence of emergence delirium, and its overall safety profile.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Control Group | Active comparator | Procedure: caudal block with bupivacaine | Patients will receive a single-shot caudal block with 1 mL/kg of 0.25% bupivacaine mixed with 1 mL of normal saline. |
| Experimental Group | Experimental | Procedure: caudal block using dexmedetomidine with bupivacaine | Patients will receive a single-shot caudal block with 1 mL/kg of 0.25% bupivacaine mixed with 1 µg/kg of dexmedetomidine (diluted in 1 mL of normal saline). |
Sex: All, ages: 2 Years to 7 Years
inclusion criteria: * ASA (American Society of Anesthesiologists) physical status I or II. * Legal guardian provides written informed consent. Exclusion Criteria * Refusal of participation by the legal guardian. * Known allergy or hypersensitivity to local anesthetics or dexmedetomidine. * Coagulation disorder or receiving anticoagulant therapy. * Active infection at or near the injection site. * Significant anatomical abnormalities of the lumbosacral spine. * Pre-existing neurological disorders, psychiatric disorders, or a history of convulsions. * Anticipated surgery time of more than 2.5 hours. * Patients with severe asthma or active wheezing.
| Facility | City | Country | Status |
|---|---|---|---|
| Ain Shams university hospitals | Cairo | Egypt | Recruiting |